Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
09:00-09:15 | 09:00-09:15 |
Secondary Mitral Valve Regurgitation: Etiology and Assessment |
Zhiyuan Song | the Southwest Hospital of AMU |
09:15-09:22 | 09:15-09:22 |
Discussion |
||
09:22-09:37 | 09:22-09:37 |
Advances in Treatment of Secondary Mitral Valve Regurgitation |
Ming Gong | Beijing Anzhen Hospital, Capital Medical University, China |
09:37-09:44 | 09:37-09:44 |
Discussion |
||
09:44-09:59 | 09:44-09:59 |
Secondary Tricuspid Valve Regurgitation: Etiology and Assessment |
Ligang Fang | |
09:59-10:06 | 09:59-10:06 |
Discussion |
||
10:06-10:21 | 10:06-10:21 |
Advances in Treatment of Secondary Tricuspid Valve Regurgitation |
Wenzhi Pan | Zhongshan Hospital,Fudan University |
10:21-10:30 | 10:21-10:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
11:00-11:02 | 11:00-11:02 |
Opening
Jianzeng Dong
The First Affiliated Hospital of Zhengzhou University / Beijing Anzhen Hospital, Capital Medical University
|
||
11:02-11:16 | 11:02-11:16 |
Emerging Data in Heart Failure from ESC, Are We Doing Enough to Improve Patients’ Survival and Quality of Life?
Jian Zhang
Fuwai Hospital of the Chinese Academy of Medical Sciences
Martin Cowie National Heart & Lung Institute, Imperial College Michael Bohm University of Saarland Cardiology, Angiology and Intensive Care Medicine |
||
11:16-11:51 | 11:16-11:51 |
Interpretation of Chinese Expert Consensus on Clinical Application of Lvabradine |
Jun Huang | Jiangsu General Hospital |
11:51-12:09 | 11:51-12:09 |
Case sharing & comments-1 |
||
12:09-12:27 | 12:09-12:27 |
Case Sharing & Comments 2 |
||
12:27-12:30 | 12:27-12:30 |
Chairman Summary
Jianzeng Dong
The First Affiliated Hospital of Zhengzhou University / Beijing Anzhen Hospital, Capital Medical University
|
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
12:30-12:45 | 12:30-12:45 |
Diabetic Cardiomyopathy: Fact or Fiction? |
Hongwei Li | Beijing Friendship Hospital, Capital Medical University |
12:45-13:00 | 12:45-13:00 |
New Evidence on SGLT-2 Inhibitors: and Its Implications |
Jing Li | Xuanwu Hospital Capital Medical University |
13:00-13:15 | 13:00-13:15 |
Diabetic Microangiopathy and Heart Failure |
Jing Yu | Lanzhou University Second Hospital |
13:15-13:30 | 13:15-13:30 |
Management of Glucose in Heart Failure: Evidence and Guideline Evolution |
Liwen Li | Guangdong Provincial People's Hospital |
13:30-13:45 | 13:30-13:45 |
Novel Treatment for Patients with Diabetes and Cardiovascular Disease |
Weimin Li | The First Affiliated Hospital of Harbin Medical University |
13:45-14:00 | 13:45-14:00 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
14:00-14:15 | 14:00-14:15 |
Diuretics |
Qing Zhang | Department of Rehabilitation Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China |
14:15-14:30 | 14:15-14:30 |
Application of Intravenous Inotropic Agents |
Ling Bai | The First Affiliated Hospital of Xian Jiaotong University |
14:30-14:45 | 14:30-14:45 |
β-Blocker and Ivabradine |
Jingmin Zhou | Zhongshan Hospital,Fudan University |
14:45-15:00 | 14:45-15:00 |
RAAS Inhibitor and Spironolactone |
Wei Jin | Shanghai Jiaotong University School of Medicine Ruijin Hospital |
15:00-15:15 | 15:00-15:15 |
Research and Prospect of New Targeted Drugs |
Yuhui Zhang | Fuwai Hospital, Chinese Academy of Medical Sciences |
15:15-15:30 | 15:15-15:30 |
Digoxin: the Initial and Long-term Treatment |
Shenghua Zhou |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
16:00-16:15 | 16:00-16:15 |
Application of Precision Treatment in Heart Failure |
Shuyang Zhang | Peking Union Medical College Hospital |
16:15-16:30 | 16:15-16:30 |
Current Status and Solutions of Heart Failure in China |
Jian Zhang | Fuwai Hospital of the Chinese Academy of Medical Sciences |
16:30-16:45 | 16:30-16:45 |
Safety of RAASi for COVID-19 Patients with Heart Failure |
Aiqun Ma | The First Affiliated Hospital of Xian Jiaotong University |
16:45-17:00 | 16:45-17:00 |
Advances in Non-Pharmacy Treatment for Heart Failure |
Tong Zou | |
17:00-17:15 | 17:00-17:15 |
New Progress on Drug Therapy for Heart Failure in 2020 |
Dingli Xu | Southern Medical University Nanfang Hospital |
17:15-17:30 | 17:15-17:30 |
Current Knowledge of Right-Sided Heart Failure |
Dongjie Xu | Jiangsu General Hospital |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
17:30-17:45 | 17:30-17:45 |
Exercise Rehabilitation Therapy for Patients with Heart Failure |
Wei Zhao | Third hospital, Peiking University |
17:45-17:52 | 17:45-17:52 |
Discussion |
||
17:52-18:07 | 17:52-18:07 |
Management of Salt Intake in Heart Failure |
jingyuan mao | |
18:07-18:14 | 18:07-18:14 |
Discussion |
||
18:14-18:29 | 18:14-18:29 |
Characteristics of Cardiopulmonary Exercise Test in Patients with Different Types of Heart Failure |
Lin Che | Tongji Hospital, Tongji University School of medicine |
18:29-18:36 | 18:29-18:36 |
Discussion |
||
18:36-18:51 | 18:36-18:51 |
Nutritional Intervention in Patients with Heart Failure |
Chunli Song | The Second Hospital of Jilin University |
18:51-19:00 | 18:51-19:00 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
19:00-19:15 | 19:00-19:15 |
Burden of Influenza in Cardiovascular Disease |
Xin Du | |
19:15-19:20 | 19:15-19:20 |
Discussion |
||
19:20-19:35 | 19:20-19:35 |
SLE-related Cardiac Disease |
Lu Zhang | China Japan Friendship Hospital |
19:35-19:40 | 19:35-19:40 |
Discussion |
||
19:40-19:55 | 19:40-19:55 |
Cardiac Function Monitoring in Cancer Treatment and Management |
Ying Liu | The First Affiliated Hospital of Dalian Medical University |
19:55-20:00 | 19:55-20:00 |
Discussion |
||
20:00-20:15 | 20:00-20:15 |
Management of Heart Failure during COVID-19 Pandemic |
Yuhua Liao | Union Hospital of Tongji Medical College,Huazhong University of Science and Technology |
20:15-20:20 | 20:15-20:20 |
Discussion |
||
20:40-20:55 | 20:40-20:55 |
Is Heart Failure with Severe Infection the Takotsubo Cardiomyopathy? |
Yushi Wang | The First Hospital of Jilin University |
20:55-21:00 | 20:55-21:00 |
Discussion |